STOCK TITAN

Microchip Technology Inc. Form 4 Filings

MCHP NASDAQ

Every Form 4 that Microchip Technology Inc. (MCHP) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow MCHP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MCHP filings page.

Rhea-AI Summary

MICROCHIP TECHNOLOGY INC (MCHP) reported that senior corporate vice president, worldwide client engagement, Joseph R. Krawczyk II acquired 41 shares of common stock on September 1, 2026 through the company’s 2001 Employee Stock Purchase Plan. Following this ESPP acquisition, he directly holds a total of 16,599 common shares.

Rhea-AI Summary

MICROCHIP TECHNOLOGY INC (MCHP) executive Stephanus Duvenhage, Sr. Corp VP, Analog Business Unit, acquired 123 shares of common stock on September 1, 2026 through the Microchip Technology Incorporated 2001 Employee Stock Purchase Plan. The shares were bought at $60.6985 per share, bringing his direct holdings to 7,210 shares. No Rule 10b5-1 trading plan is reported.

Rhea-AI Summary

MICROCHIP TECHNOLOGY INC (MCHP) reported that officer Mathew B. Bunker, Senior Corporate Vice President, Operations, acquired 53 shares of common stock on September 1, 2026 through a grant/award transaction. The shares were obtained under the company’s 2001 Employee Stock Purchase Plan in an exempt transaction and bring his direct holdings to 20,243 shares.

Rhea-AI Summary

For MICROCHIP TECHNOLOGY INC (MCHP), reporting person Steve Sanghi reported the vesting and conversion of 28,853 Restricted Stock Units into an equal number of shares of common stock on August 15, 2026 at an exercise price of $80.26 per share. These shares were acquired as indirectly held through a trust and a family limited partnership. On the same date, 11,931 indirectly held common shares at $80.26 per share were delivered or withheld for payment of exercise price or tax liability. A related footnote states that the RSU grant will vest in four quarterly installments through February 15, 2027, subject to continued service, and clarifies that this amended Form 4 corrects the vesting date disclosure.

Rhea-AI Summary

MICROCHIP TECHNOLOGY INC (MCHP) reported that Senior Corporate VP and CFO James Eric Bjornholt sold 4,112 shares of common stock on 2026-08-25 at $75.32 per share. The shares were held indirectly in a trust, and following the sale the trust holds 28,573 shares. The transaction was effected under a Rule 10b5-1 trading plan adopted on March 12, 2026.

Rhea-AI Summary

MICROCHIP TECHNOLOGY INC (MCHP) reported amended insider transactions by Senior Corporate VP and CFO James Eric Bjornholt. On August 15, 2026, he exercised or converted restricted stock units and performance stock units into 3,021 shares of common stock at a conversion price of $80.26 per share, held indirectly through a trust. In related code F transactions, 1,296 shares of common stock were delivered or withheld for payment of exercise price or tax liability. Footnotes describe detailed RSU and PSU vesting schedules tied to cumulative non-GAAP operating margin over 12 quarters ending September 30, 2024, and state that this amended Form 4 corrects the performance measure date for the PSU grant.

Rhea-AI Summary

MICROCHIP TECHNOLOGY INC (MCHP) reported insider equity activity by Senior Corporate VP and CFO James Eric Bjornholt on August 17, 2026. Restricted Stock Units covering 2,226 shares and Performance Stock Units covering 1,952 shares were exercised into common stock at a conversion price of $80.26 per share and held indirectly through a trust. In connection with these vestings, a total of 1,791 shares of common stock were delivered or withheld to cover the exercise price or tax obligations, including 837 shares explicitly identified as withheld to pay tax liability rather than sold.

Rhea-AI Summary

Microchip Technology Inc (MCHP) reported insider equity activity by Chief Operating Officer Richard J. Simoncic. On August 15, 2026, restricted stock units and performance stock units covering a total of 3,042 shares of common stock were exercised or converted at an exercise price of $80.26 per share, with the resulting common shares held indirectly in a trust. In connection with these exercises, 1,290 shares of common stock were delivered or withheld to pay the exercise price or related tax liabilities. The PSUs were tied to Microchip’s cumulative non‑GAAP operating margin performance over 12 quarters ending September 30, 2024, with vesting and delivery occurring as the awards vested.

Rhea-AI Summary

MICROCHIP TECHNOLOGY INC (MCHP) reported an insider equity transaction by President, CEO and Chair of the Board Steve Sanghi. On August 15, 2026, Sanghi exercised 28,853 restricted stock units, converting them into an equal number of shares of common stock at an exercise price of $80.26 per share. Of these shares, 11,931 were delivered or withheld to cover the exercise price or tax liability, with the remaining shares held indirectly through a trust and a family limited partnership. Following these transactions, Sanghi’s remaining restricted stock unit balance was 57,708 units, and his indirect common stock holdings referenced in the footnotes were about 9.4 million shares across The Sanghi Trust and The Sanghi Family Limited Partnership.

Rhea-AI Summary

MICROCHIP TECHNOLOGY INC (MCHP) reported that Senior Corporate VP and CFO James Eric Bjornholt exercised previously granted restricted stock units and performance stock units into common stock on August 15, 2026. A portion of the resulting common shares held indirectly in a trust was delivered or withheld to cover the exercise price or tax liability, with no open‑market purchases or sales reported.

Rhea-AI Summary

Microchip Technology Inc. (MCHP) reported that senior officer Joseph R. Krawczyk II had multiple equity awards vest and convert on August 15, 2026. In total, 2,477 Restricted Stock Units and Performance Stock Units converted into common stock at a reference price of $80.26 per share, with 1,063 shares delivered or withheld to pay the exercise price or tax liabilities. Performance Stock Units were earned based on Microchip’s cumulative non-GAAP operating margin over a 12-quarter period ending June 30, 2025, with earned PSUs vesting on August 15, 2026.

Rhea-AI Summary

MICROCHIP TECHNOLOGY INC (MCHP) reported insider equity activity by Mathew B. Bunker, its Senior Corporate Vice President, Operations. On August 15, 2026, he exercised and converted performance stock units and restricted stock units into 4,118 shares of common stock at an exercise price of $80.26 per share, with 1,150 shares delivered or withheld to cover the exercise price or tax liabilities. The performance stock units were earned based on Microchip’s cumulative non-GAAP operating margin over 12 quarters ending June 30, 2025, targeting a 40.0% margin, and vested on August 15, 2026, with vested shares delivered upon vesting.

Rhea-AI Summary

MICROCHIP TECHNOLOGY INC (MCHP) reported that Chief Operating Officer Richard J. Simoncic had equity awards vest and convert into common stock on August 17, 2026. 2,226 Restricted Stock Units vested and were delivered in common shares, and 1,952 Performance Stock Units earned under a 12‑quarter performance period ending June 30, 2025 also vested and converted into common stock. The resulting 4,178 common shares were held indirectly in a trust, at a stated value of $80.26 per share. In separate code F transactions, 943 shares and 827 shares of common stock held by the trust were delivered or withheld to satisfy the exercise price or tax liability associated with these vestings.

Rhea-AI Summary

MICROCHIP TECHNOLOGY INC (MCHP) reported that President and CEO Steve Sanghi exercised and vested equity awards tied to company performance. On August 17, 2026, restricted stock units for 7,020 shares and performance stock units for 6,157 shares converted into common stock at an exercise price of $80.26 per share. A total of 2,903 and 2,546 common shares were delivered or withheld to cover the exercise price or tax liabilities. Footnotes state that roughly 9.4 million shares are held indirectly through The Sanghi Trust and The Sanghi Family Limited Partnership.

Rhea-AI Summary

Microchip Technology Inc. (MCHP) reported that Senior Corporate VP and CFO James Eric Bjornholt had Restricted Stock Units and Performance Stock Units convert into a total of 4,178 shares of common stock on August 17, 2026, held indirectly through a trust. Of these, 954 shares were delivered or withheld to cover exercise price or tax liability, and 837 shares were sold at $80.26 per share.

The RSUs vest in full on August 17, 2026, contingent on continued service. The PSUs were earned based on Microchip’s cumulative non-GAAP operating margin over 12 quarters ending June 30, 2025, with target awards tied to a 40.0% margin.

Rhea-AI Summary

For MICROCHIP TECHNOLOGY INC (MCHP), director Karen Marie Rapp reported equity compensation activity. On August 18, 2026, she received a grant of 2,557 Restricted Stock Units, each representing a contingent right to one share of common stock, scheduled to vest in full on August 18, 2027 as long as she remains a service provider through that date; vested shares will then be delivered to her. On August 17, 2026, 3,090 Restricted Stock Units vested in full and were converted into 3,090 shares of common stock at a stated value of $80.26 per share, increasing her directly held common stock position to 14,227 shares after the transactions.

Rhea-AI Summary

MICROCHIP TECHNOLOGY INC (MCHP) director Victor Peng reported equity compensation activity involving restricted stock units and common stock. On August 18, 2026, he received a grant of 2,557 Restricted Stock Units, each representing a contingent right to one share of common stock; these RSUs will vest in full on August 18, 2027 if he remains a service provider, with shares delivered upon vesting.

On August 17, 2026, 3,090 Restricted Stock Units vested in full and were converted into 3,090 shares of common stock at an exercise price of $80.26 per share, with vested shares delivered to him upon vest. Following this conversion, he held 5,416 shares of common stock indirectly, including 5,370 shares held by The Peng Revocable Trust and 46 shares held in an IRA in his name.

Rhea-AI Summary

MICROCHIP TECHNOLOGY INC (MCHP) reported equity compensation and a routine equity settlement for director Mitchell R. Little. On August 18, 2026, he received a grant of 2,557 Restricted Stock Units, each representing one share of common stock, scheduled to vest in full on August 18, 2027 if he remains a service provider. On August 17, 2026, 472 RSUs vested in full and were converted into 472 shares of common stock at $80.26 per share, increasing his directly held common stock to 1,558 shares.

Rhea-AI Summary

MICROCHIP TECHNOLOGY INC (MCHP) reported equity compensation activity for director Richard B. Cassidy II. On August 18, 2026 he received a grant of 2,557 Restricted Stock Units (RSUs), each representing a contingent right to one share of common stock; these RSUs will vest in full on August 18, 2027 as long as he remains a service provider, with shares delivered upon vesting. On August 17, 2026 a prior RSU award of 3,090 units vested in full, and the units were converted into 3,090 shares of common stock at a stated value of $80.26 per share, increasing his directly held common stock to 4,348 shares.

Rhea-AI Summary

MICROCHIP TECHNOLOGY INC (MCHP) director Matthew W. Chapman reported equity compensation and a related share delivery. On August 18, 2026, he received a grant of 2,557 Restricted Stock Units, each representing a contingent right to one share of common stock, which will vest in full on August 18, 2027 as long as he remains a service provider through that date; vested shares will then be delivered to him.

On August 17, 2026, 3,090 Restricted Stock Units vested in full and the corresponding 3,090 shares of common stock were delivered to him at an exercise/conversion price of $80.26 per share. Following this delivery, he directly held 20,755 shares of common stock.

Rhea-AI Summary

MICROCHIP TECHNOLOGY INC (MCHP) reported insider equity activity by director Ellen Barker. On August 18, 2026, she received a grant of 2,557 Restricted Stock Units (RSUs), each representing one share of common stock, scheduled to vest in full on August 18, 2027, contingent on continued service. On August 17, 2026, 3,090 RSUs vested in full and were converted into 3,090 shares of common stock at an exercise price of $80.26 per share, increasing her directly held common stock position to 6,887 shares.

Rhea-AI Summary

Sanghi Steve reported acquisition or exercise transactions in this Form 4 filing.

MICROCHIP TECHNOLOGY INC reported that President, CEO and Chair of the Board Steve Sanghi received a grant of 4,514 restricted stock units, each representing a contingent right to one share of common stock. These units vest in full on May 15, 2028, contingent on continued service, with shares delivered upon vesting. The filing also lists 9,410,407 shares of common stock held indirectly through The Sanghi Trust and The Sanghi Family Limited Partnership. No open-market purchases or sales were reported.

Rhea-AI Summary

Krawczyk Joseph R II reported acquisition or exercise transactions in this Form 4 filing.

MICROCHIP TECHNOLOGY INC granted 302 Restricted Stock Units to senior officer Joseph R. Krawczyk II on August 7, 2026. Each unit represents one share of common stock and will vest in full on August 15, 2027, contingent on continued service. After this grant, Krawczyk holds 15,144 shares of common stock directly.

Rhea-AI Summary

Bunker Mathew B reported acquisition or exercise transactions in this Form 4 filing.

Microchip Technology Inc. senior executive Mathew B. Bunker received a grant of 280 Restricted Stock Units, each representing one share of common stock. The units vest in full on August 15, 2027, contingent on continued service. Following this award, he directly holds 17,222 shares of common stock.

Rhea-AI Summary

Bjornholt James Eric reported acquisition or exercise transactions in this Form 4 filing.

MICROCHIP TECHNOLOGY INC reported that Senior Corporate VP and CFO James Eric Bjornholt received a grant of 409 restricted stock units on August 7, 2026. Each unit represents a contingent right to receive one share of common stock and will vest in full on August 15, 2027, provided he remains a service provider through that date. Vested shares will be delivered to him upon vesting. In addition, an indirect holding entry shows 28,573 shares of common stock held through a trust.

Rhea-AI Summary

Simoncic Richard J reported acquisition or exercise transactions in this Form 4 filing.

Microchip Technology Chief Operating Officer Richard J. Simoncic reported new equity awards rather than open‑market trades. He received 3,524 Performance Stock Units and 3,523 Restricted Stock Units, each representing a contingent right to one share of common stock as compensation.

The restricted stock units will vest in full on August 15, 2030 if he remains a service provider, with shares delivered at vesting. The performance stock units are tied to Microchip’s cumulative non‑GAAP operating margin over 12 quarters ending June 30, 2029, with the reported 3,524 units reflecting a target level based on achieving a 33.5% margin. Actual PSU shares earned may be higher or lower depending on performance, and earned PSUs will also vest on August 15, 2030.

Rhea-AI Summary

Sanghi Steve reported acquisition or exercise transactions in this Form 4 filing.

Microchip Technology President, CEO and Chair Steve Sanghi reported new equity awards rather than open-market trades. He received 21,986 Performance Stock Units and 14,658 Restricted Stock Units, each representing a right to receive one share of common stock at no purchase price.

The RSUs and any earned PSUs are scheduled to vest on August 15, 2030, if he remains a service provider through that date. PSU payouts will depend on Microchip’s cumulative non-GAAP operating margin over 12 quarters ending June 30, 2029, with the target based on achieving a 33.5% margin.

The filing also reports 9,410,407 Microchip common shares held indirectly, including 3,504,535 shares in The Sanghi Trust and 5,905,872 shares in The Sanghi Family Limited Partnership.

Rhea-AI Summary

Krawczyk Joseph R II reported acquisition or exercise transactions in this Form 4 filing.

Microchip Technology senior vice president Joseph R. Krawczyk II reported new equity awards rather than open-market trades. He received 1,480 Restricted Stock Units, each representing a right to one share of common stock, which will vest in full on August 15, 2030 if he remains a service provider through that date.

He also received 1,480 Performance Stock Units tied to Microchip’s cumulative non-GAAP operating margin over 12 quarters ending June 30, 2029. The target PSU amount assumes a 33.5% cumulative non-GAAP operating margin, and the actual shares earned may be higher or lower depending on performance. Following these awards, he directly holds 15,144 shares of common stock, with the PSUs and RSUs to be settled in shares upon vesting.

Rhea-AI Summary

Bunker Mathew B reported acquisition or exercise transactions in this Form 4 filing.

Microchip Technology senior vice president of operations Mathew B. Bunker reported new equity awards. He received 1,692 Performance Stock Units and 1,691 Restricted Stock Units, each representing the right to one share of common stock.

The PSUs are tied to Microchip’s cumulative non-GAAP operating margin over 12 quarters ending June 30, 2029, with the target award based on achieving 33.5% cumulative margin. Both the RSUs and any PSUs ultimately earned are scheduled to vest on August 15, 2030, contingent on continued service, with shares delivered upon vesting. Following these awards, Bunker directly holds 17,222 shares of common stock in addition to the new units.

Rhea-AI Summary

Bjornholt James Eric reported acquisition or exercise transactions in this Form 4 filing.

Microchip Technology Inc. reported that Senior VP and CFO James Eric Bjornholt received new equity awards. He was granted 3,009 restricted stock units and 3,009 performance stock units, each representing a right to receive one share of common stock.

The restricted stock units vest in full on August 15, 2030, if he remains a service provider, with shares delivered at vesting. The performance stock units can pay out more or fewer than 3,009 shares based on Microchip’s cumulative non-GAAP operating margin over 12 quarters ending June 30, 2029, with the target tied to a 33.5% margin and vesting on August 15, 2030. The filing also shows 28,573 common shares held indirectly in a trust.

Rhea-AI Summary

Microchip Technology’s chief operating officer, Richard J. Simoncic, reported an open-market sale of company stock held through a trust. The trust sold 5,000 shares of common stock on June 4, 2026 at an average price of $97.515 per share. After this transaction, the trust’s indirect holdings related to Simoncic totaled 130,508 shares, indicating the sale represented a small portion of the reported indirect position.

Rhea-AI Summary

Microchip Technology director Matthew W. Chapman reported an open-market sale of 3,000 shares of Common Stock on May 28, 2026 at an average price of $97.5152 per share. After this transaction, he directly holds 17,665 shares of Microchip Technology stock.

Rhea-AI Summary

Microchip Technology chief operating officer Richard J. Simoncic reported an indirect open-market sale of 5,000 shares of Common Stock held by a trust on May 22, 2026, at an average price of $93.435 per share. After this transaction, his reported indirect holdings were 135,508 shares.

Rhea-AI Summary

MICROCHIP TECHNOLOGY INC Senior VP and CFO James Eric Bjornholt, through a trust, reported two open-market sales of Microchip common stock. The trust sold 3,667 shares in total, with 334 shares sold at about $93.11 per share and 3,333 shares sold at $90.64 per share.

These transactions were executed as indirect holdings "held by Trust" and were carried out under a pre-arranged Rule 10b5-1 trading plan adopted by the reporting person. Such plans automate trading under preset instructions, making the timing of these sales more routine.

Rhea-AI Summary

MICROCHIP TECHNOLOGY INC director Matthew W. Chapman reported an open-market sale of 10,000 shares of Common Stock. The transaction occurred on May 15, 2026 at a price of $95.4799 per share. Following this sale, he directly holds 20,665 shares of Microchip stock.

Rhea-AI Summary

Microchip Technology’s chief operating officer, Richard J. Simoncic, reported routine equity compensation activity involving restricted and performance stock units that vested into common stock. On May 15, 2026, awards converted into a total of 6,252 shares of common stock at a stated value of $93.85 per share.

Shares are held indirectly through a trust. To cover tax obligations tied to these vesting events, the trust disposed of 1,788 shares at $93.85 via tax-withholding transactions, which are not open-market sales. The trust also sold 83 shares of common stock in an open‑market transaction at $93.85 per share, leaving indirect holdings of about 136,637 shares after the reported transactions.

Rhea-AI Summary

Microchip Technology CEO Steve Sanghi reported routine equity compensation activity involving restricted and performance stock units that vested on May 15, 2026. Entities associated with him exercised derivative awards for a total of 41,903 shares of Microchip common stock at a conversion price of $93.85 per share. To cover tax obligations, 17,330 shares were delivered back as tax-withholding dispositions rather than open-market sales.

Following these transactions, entities including The Sanghi Trust and The Sanghi Family Limited Partnership collectively held around 9.39 million shares of common stock indirectly. Footnotes explain that the performance stock units were tied to Microchip’s cumulative non-GAAP operating margin over 12 quarters ending March 31, 2025, with a target margin of 40.0%. Earned PSUs and certain RSUs vested on May 15, 2026, and additional RSUs are scheduled to vest in equal quarterly installments through February 15, 2027, subject to continued service.

Rhea-AI Summary

Microchip Technology senior vice president Joseph R. Krawczyk II reported routine equity compensation activity tied to vesting stock units. On May 15, 2026, he exercised restricted and performance stock units into common stock and used a portion of the resulting shares to satisfy tax obligations through share withholding. These are not open-market purchases or sales, but standard compensation-related exercises and tax-withholding dispositions.

Rhea-AI Summary

Microchip Technology senior vice president Mathew B. Bunker reported compensation-related share activity, not open-market trading. On May 15, 2026, he exercised or converted derivative awards into 3,656 shares of common stock and used 1,021 shares, valued at $93.85 each, to cover tax or exercise obligations, resulting in a net increase in directly held shares.

Rhea-AI Summary

Microchip Technology’s Senior VP and CFO James Eric Bjornholt reported compensation-related equity activity rather than open-market trading. On May 15, 2026, he exercised a total of 6,422 restricted and performance stock units into common stock at $93.85 per share.

To cover tax obligations, 2,755 common shares were disposed of via tax-withholding transactions, not market sales. After these events, a trust associated with him holds 29,016 shares of common stock indirectly, and he also retains 778 performance stock units that remain outstanding under Microchip’s equity incentive plan.

Rhea-AI Summary

MICROCHIP TECHNOLOGY INC senior vice president of operations Mathew B. Bunker reported an open-market sale of company stock. On May 13, 2026, he sold 10,571 shares of Common Stock at an average price of $96.8835 per share. After this transaction, he directly holds 14,587 shares of Microchip Technology common stock.

Rhea-AI Summary

Microchip Technology’s chief operating officer Richard J. Simoncic reported an open-market sale of Common Stock held indirectly through a trust. On May 13, 2026, the trust sold 10,000 shares at an average price of $97.546 per share. After this transaction, the trust continues to hold 136,127 shares of Microchip Technology Common Stock indirectly attributable to Simoncic.

Rhea-AI Summary

Simoncic Richard J reported acquisition or exercise transactions in this Form 4 filing.

Microchip Technology's chief operating officer, Richard J. Simoncic, received a grant of 371 restricted stock units, each representing one share of common stock. These units vest in full on May 15, 2027, if he remains a service provider through that date. The filing also shows 146,127 shares of common stock held indirectly through a trust.

Rhea-AI Summary

Sanghi Steve reported acquisition or exercise transactions in this Form 4 filing.

Microchip Technology Inc. reported that President, CEO and Chair of the Board Steve Sanghi received a grant of 3,446 restricted stock units. Each unit represents a contingent right to receive one share of Microchip common stock. The units will vest in full on May 15, 2028, provided he remains a service provider through that date, and vested shares will be delivered upon vesting.

Following this award, Sanghi holds 3,446 restricted stock units directly and 9,385,834 shares of common stock indirectly, with 3,479,962 shares held by The Sanghi Trust and 5,905,872 shares held by The Sanghi Family Limited Partnership.

Rhea-AI Summary

Krawczyk Joseph R II reported acquisition or exercise transactions in this Form 4 filing.

Microchip Technology Inc. senior vice president Joseph R. Krawczyk II reported a compensation-related award of 212 restricted stock units, each representing a contingent right to receive one share of common stock. These units will vest in full on May 15, 2027, provided he remains a service provider through that date.

Upon vesting, the corresponding shares of common stock will be delivered to him. The filing also shows he directly holds 13,926 shares of Microchip common stock after the reported transactions, indicating this grant is modest compared with his existing equity position.

Rhea-AI Summary

Bunker Mathew B reported acquisition or exercise transactions in this Form 4 filing.

Microchip Technology Inc. senior vice president of operations Mathew B. Bunker received a grant of 203 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Microchip common stock. The RSUs will vest in full on May 15, 2027, provided he remains a service provider through that date, and vested shares will be delivered upon vesting.

After this filing, Bunker is shown holding 25,158 shares of Microchip common stock directly, along with the 203 newly granted RSUs.

Rhea-AI Summary

Bjornholt James Eric reported acquisition or exercise transactions in this Form 4 filing.

Microchip Technology Senior VP and CFO James Eric Bjornholt reported a compensation-related equity grant and his indirect holdings. He received 279 restricted stock units, each representing a contingent right to one share of Microchip common stock. These units will vest in full on May 15, 2027, provided he continues as a service provider through that date, and the vested shares will be delivered upon vesting.

The filing also shows 28,573 shares of common stock held indirectly through a trust. No open-market purchases or sales were reported, making this a routine update to disclose equity awards and existing indirect ownership.

Rhea-AI Summary

Microchip Technology (MCHP) director, president, CEO and chair Steve Sanghi reported two indirect open‑market sales of common stock by entities associated with him under a Rule 10b5‑1 trading plan. On April 30, 2026, 33,502 shares were sold at an average price of $92.3729 per share. On May 1, 2026, 76,469 shares were sold at an average price of $93.5843 per share, for total reported sales of 109,971 shares. After these transactions, 9,385,834 shares of Microchip Technology common stock are reported as indirectly held, including shares held by The Sanghi Trust and The Sanghi Family Limited Partnership.

Rhea-AI Summary

Microchip Technology President, CEO and Chair Steve Sanghi reported an open-market sale of 416,581 shares of Common Stock at $88.5329 per share under a pre-arranged Rule 10b5-1 trading plan. After this indirect sale through a trust and a family limited partnership, he continues to hold 9,495,805 shares indirectly.

Rhea-AI Summary

Microchip Technology chief operating officer Richard J. Simoncic reported new equity awards and an ownership correction. On April 1, 2026, he received grants of restricted stock units and performance stock units covering 10,667, 8,089 and 4,779 restricted units and 10,667, 8,090 and 4,780 performance units, each representing the right to receive one share of common stock.

The restricted units vest over quarterly schedules from May 15, 2027 through February 15, 2029, with another grant vesting in full on May 15, 2030. The performance units are tied to cumulative non-GAAP operating margin targets of 30.5%, 31.0% and 31.5% over measurement periods ending March 31, 2027, March 31, 2028 and March 31, 2029, with vesting dates matching the related restricted units.

The filing also shows a bona fide gift of 1,075 common shares on May 15, 2024, held indirectly by a trust, and corrects previously reported beneficial ownership to 146,127 common shares for that indirect position.